12
67
Growth Score 12 in past quarter
-6 pts
Heat Score 67 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
324783
OCMS Bio is a monoclonal antibody discovery tools company.
Scott Dessain: Founder and Chief Scientific OfficerPast Role: Thomas Jefferson University, Assistant Professor of Medicine
About the Company
OCMS Bio® is a company that develops monoclonal antibody discovery tools. On-Cell mAb Screening is a proprietary technology that greatly accelerates antibody discovery. OCMS® fluorescent imaging methods revolutionize mAb discovery from patient-derived antibodies, transgenic mouse models, and AI antibody engineering. AI-driven pandemic prevention
is a major focus of our internal research program.